GO:0006487 protein N-linked glycosylation: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006487 (protein N-linked glycosylation) is the biological process that attaches a preassembled oligosaccharide to the amide nitrogen of asparagine residues in the sequon Asn-X-Ser/Thr of nascent polypeptides.
• The process is essential for protein folding, stability, trafficking, and cell-surface presentation, and it modulates protein-protein interactions in health and disease.
• N-linked glycans regulate viral pathogenesis, including flavivirus particle formation and hepatitis B surface protein function.
• Altered N-linked glycosylation of immune checkpoint proteins such as PD-L1/PD-1 is an emerging target for cancer diagnosis and therapy.
• N-glycosylation can protect proteins from deamidation and regulate prion protein neurotoxicity, linking the pathway to neurodegeneration.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal dissection of N-linked glycosylation genes in disease and biotechnology.
Description
Protein N-linked glycosylation (GO:0006487) is a co- and post-translational modification in which a lipid-linked oligosaccharide is transferred to the amide nitrogen of an asparagine residue within the consensus sequon Asn-X-Ser/Thr of a growing polypeptide. This process occurs in the endoplasmic reticulum and is conserved across eukaryotes, and it is one of the most abundant protein modifications in the secretory pathway. Because the attached glycan influences folding, stability, trafficking, and molecular recognition, N-linked glycosylation is central to cell biology and to the mechanisms of many human diseases. Researchers study GO:0006487 to understand how glycans control protein function and to identify therapeutic opportunities. For example, N-linked glycosylation of the flavivirus E protein contributes to viral particle formation, and glycosylation of the orthoflavivirus NS1 protein modulates progeny virion assembly. In cancer, N-linked glycosylation of PD-L1/PD-1 is an emerging target for diagnosis and treatment. In neurodegeneration, N-glycosylation is a potent regulator of prion protein neurotoxicity, and it can prevent deamidation of glycopeptides and glycoproteins. These findings illustrate why the pathway is a high-value subject for functional genomics and drug discovery. This article summarizes the definition, mechanism, key genes, disease links, and research methods for GO:0006487, with a focus on how CRISPR-based models can be used to test causality. All statements are based on the verified literature cited by number.
protein N-linked glycosylation At A Glance
| GO ID | GO:0006487 |
|---|---|
| GO term | protein N-linked glycosylation |
| Ontology | biological_process |
| Synonym | None listed in QuickGO |
| Major function | Covalent attachment of a preassembled oligosaccharide to asparagine residues of nascent polypeptides, influencing folding, stability, trafficking, and interactions |
| Subcellular location | Endoplasmic reticulum and secretory pathway |
| Consensus sequon | Asn-X-Ser/Thr, where X is any amino acid except proline |
| Representative pathways | Flavivirus particle formation, hepatitis B surface protein function, immune checkpoint regulation |
| Disease relevance | Cancer, neurodegeneration, viral infection, and protein stability disorders |
What Is GO:0006487?
In our own words, GO:0006487 (protein N-linked glycosylation) is the biological process in which a preassembled oligosaccharide is covalently attached to the amide nitrogen of an asparagine residue in a target protein, typically within the sequon Asn-X-Ser/Thr, as the protein is synthesized and translocated into the endoplasmic reticulum. This modification is a form of glycosylation that occurs on the nitrogen atom of asparagine, distinguishing it from O-linked glycosylation, and it is a key step in the maturation of many secretory and membrane proteins.
Why Is protein N-linked glycosylation Important in Cell Biology?
GO:0006487 is important because N-linked glycans are not merely decorative; they act as functional switches that determine whether a protein folds correctly, reaches the cell surface, or is recognized by the immune system. Disruption of the pathway affects viral assembly, cancer immune evasion, and neurodegeneration, making it a central node for both basic and translational research.
• Controls protein folding and quality control in the endoplasmic reticulum.
• Regulates protein stability and protects against deamidation.
• Modulates viral particle formation and secretion, as shown for flaviviruses and hepatitis B virus.
• Influences immune checkpoint function through PD-L1/PD-1 glycosylation in cancer.
• Regulates prion protein neurotoxicity in neurodegenerative disease models.
• Affects transporter function, as illustrated by SLC6 transporter glycosylation.
• Provides biomarkers and therapeutic targets for cancer diagnosis and treatment.
• Is a key consideration in biotherapeutic manufacturing and glycoprotein quality control.
What Happens During protein N-linked glycosylation?
Step 1: Assembly of the lipid-linked oligosaccharide precursor
In simple terms: First, the cell builds a sugar tree on a lipid carrier inside the endoplasmic reticulum membrane.
N-linked glycosylation begins with the stepwise assembly of a lipid-linked oligosaccharide precursor on a dolichol phosphate carrier in the endoplasmic reticulum membrane. This precursor is then flipped and transferred to the lumenal side, where it serves as the donor for the en bloc transfer reaction.
Step 2: En bloc transfer to the Asn-X-Ser/Thr sequon
In simple terms: The sugar tree is then attached in one piece to a specific asparagine on the target protein.
The oligosaccharyltransferase complex catalyzes the transfer of the preassembled oligosaccharide to the amide nitrogen of an asparagine residue within the consensus sequon Asn-X-Ser/Thr of a nascent polypeptide. This en bloc transfer is the defining catalytic event of GO:0006487 and occurs co-translationally as the polypeptide enters the endoplasmic reticulum.
Step 3: Processing and maturation of the N-glycan
In simple terms: After attachment, the sugar tree is trimmed and rebuilt into mature forms that help the protein fold and function.
Following transfer, the N-linked glycan undergoes trimming and remodeling by glycosidases and glycosyltransferases in the endoplasmic reticulum and Golgi apparatus. These processing steps generate high-mannose, hybrid, and complex glycans that influence protein folding, stability, and interactions. The mature glycan can also protect proteins from deamidation, as shown for glycopeptides and glycoproteins.
Step 4: Functional consequences for protein fate
In simple terms: The final glycan helps decide where the protein goes and what it does.
N-linked glycans affect protein trafficking, cell-surface presentation, and molecular recognition. For example, N-linked glycosylation of the flavivirus E protein contributes to viral particle formation, and glycosylation of the orthoflavivirus NS1 protein modulates progeny virion assembly. In the immune system, N-linked glycosylation of PD-L1/PD-1 regulates checkpoint interactions and is an emerging target for cancer diagnosis and treatment.
Step 5: Regulation by cellular and disease contexts
In simple terms: The pathway can be turned up or down depending on the cell state and disease.
The extent and pattern of N-linked glycosylation are regulated by the availability of precursors, the activity of glycosyltransferases, and the folding status of the target protein. In disease contexts, altered glycosylation of prion protein regulates neurotoxicity, and glycosylation changes in the hepatitis B surface protein impact autophagy, HBV replication, and secretion. These context-dependent effects make GO:0006487 a dynamic and disease-relevant process.
Key Genes Involved in GO:0006487 protein N-linked glycosylation
The following genes and proteins are central to the N-linked glycosylation pathway and are frequently studied in functional genomics and disease research.
| Gene | Major Role | Research Relevance |
|---|---|---|
| OST complex subunits | Catalyze en bloc transfer of oligosaccharide to asparagine | Core enzymatic machinery of GO:0006487 |
| DOLK | Synthesizes dolichol phosphate carrier | Precursor supply for lipid-linked oligosaccharide |
| ALG genes | Assemble the lipid-linked oligosaccharide precursor | Stepwise glycan assembly in the ER |
| MAN1B1 | Trims mannose residues during glycan processing | Glycan maturation and quality control |
| MGAT1 | Initiates complex N-glycan formation | Hybrid and complex glycan synthesis |
| B4GALT1 | Adds galactose to N-glycans | Complex glycan remodeling |
| ST6GAL1 | Adds sialic acid to N-glycans | Terminal glycan modification |
| FUT8 | Adds core fucose to N-glycans | Antibody effector function and cancer biology |
| PD-L1 (CD274) | Immune checkpoint protein with N-linked glycosylation | Cancer immunotherapy target |
| PD-1 (PDCD1) | Immune checkpoint receptor with N-linked glycosylation | Cancer immunotherapy target |
| Prion protein (PRNP) | Neuronal glycoprotein with N-linked glycans | Neurodegeneration and neurotoxicity |
| SLC6 transporters | Membrane transporters modified by N-linked glycans | Transport function and pharmacology |
| Flavivirus E protein | Viral envelope protein with N-linked glycans | Viral particle formation |
| Orthoflavivirus NS1 | Nonstructural protein with N-linked glycosylation | Progeny virion assembly |
| Hepatitis B surface protein | Viral surface antigen with N-linked glycans | Autophagy, replication, and secretion |
| OST1/OST2 | Oligosaccharyltransferase catalytic subunits | Enzymatic core of N-linked glycosylation |
| RPN1/RPN2 | Oligosaccharyltransferase accessory subunits | Substrate recognition and complex stability |
How Is protein N-linked glycosylation Regulated?
N-linked glycosylation is regulated at multiple levels, including the availability of the lipid-linked oligosaccharide precursor, the expression and activity of oligosaccharyltransferase and glycan-processing enzymes, and the folding status of the target protein. In disease contexts, glycosylation patterns can be altered by viral infection and oncogenic transformation, as seen for flavivirus E protein, orthoflavivirus NS1, hepatitis B surface protein, and PD-L1/PD-1. These regulatory inputs make GO:0006487 responsive to cellular stress, metabolic state, and immune signaling.
protein N-linked glycosylation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PD-L1 (CD274) | Cancer immune evasion and immunotherapy response | Knockout and point-mutation models in cancer cell lines |
| PRNP | Prion disease and neurodegeneration | Knock-in of glycosylation-site mutations in neuronal cells |
| Flavivirus E protein | Viral particle formation and pathogenesis | Knockout of glycosylation sites in viral clones |
| Orthoflavivirus NS1 | Progeny virion assembly | Point-mutation models in infected cells |
| Hepatitis B surface protein | Autophagy, HBV replication, and secretion | Knockout and knock-in models in hepatoma cells |
Cancer and immune checkpoint regulation
N-linked glycosylation of PD-L1/PD-1 is an emerging target for cancer diagnosis and treatment. Glycans on these checkpoint proteins influence their interactions and stability, and altered glycosylation can affect immune evasion. This makes glycosylation enzymes and glycan-binding proteins attractive candidates for therapeutic intervention in oncology.
Neurodegeneration and prion disease
N-glycosylation is a potent regulator of prion protein neurotoxicity. Changes in the glycan status of prion protein can modulate its toxic gain of function, linking GO:0006487 to neurodegenerative mechanisms. In addition, N-linked glycosylation can prevent deamidation of glycopeptides and glycoproteins, which is relevant to protein stability in aging and disease.
Viral infection and pathogenesis
N-linked glycosylation of the flavivirus E protein contributes to viral particle formation, and glycosylation of the orthoflavivirus NS1 protein modulates progeny virion assembly. In hepatitis B virus, N-linked glycosylation modifications in the surface protein impact cellular autophagy, HBV replication, and HBV secretion. These findings highlight the pathway as a host-virus interface and a potential antiviral target.
Transporters and protein function
N-linked glycosylation affects SLC6 transporter function, as shown by computational and experimental studies. Glycan modifications can influence transporter trafficking, stability, and substrate handling, with implications for pharmacology and inherited transport disorders.
From protein N-linked glycosylation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a glycosylation gene essential for protein function? | CRISPR knockout cell line |
| Does a specific sequon mediate glycan attachment? | Point mutation of Asn to Gln in the target gene |
| Can a disease-associated glycan variant be corrected? | Knock-in of wild-type or mutant glycosylation site |
| Where does the glycosylated protein localize? | Tagged knock-in with fluorescent or affinity tag |
| Does overexpression of a glycosyltransferase alter phenotype? | Overexpression cell model |
| Which glycosylation genes are required for viral replication? | Genome-wide CRISPR library screening |
How to Study the protein N-linked glycosylation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Mass spectrometry glycoproteomics | Site occupancy and glycan composition | Mapping N-glycosylation of viral and immune proteins |
| Lectin blotting | Presence of specific glycan epitopes | Detecting changes in glycosylation state |
| CRISPR knockout screening | Gene requirement for a phenotype | Identifying glycosylation genes in viral infection |
| Site-directed mutagenesis | Effect of removing a sequon | Testing Asn-to-Gln mutants |
| Fluorescence imaging | Subcellular localization of glycoproteins | Trafficking studies of tagged proteins |
| Co-immunoprecipitation | Protein-protein interactions of glycosylated proteins | Studying PD-L1/PD-1 interactions |
| Flow cytometry | Cell-surface expression of glycoproteins | Immune checkpoint and transporter studies |
| Enzymatic deglycosylation assays | Sensitivity of protein to PNGase F or Endo H | Confirming N-linked glycan attachment |
Glycoproteomics and mass spectrometry
Mass spectrometry-based glycoproteomics identifies occupied N-glycosylation sites and glycan compositions on target proteins. This approach is used to map site-specific glycosylation of viral proteins, immune checkpoints, and transporters.
Lectins, antibodies, and glycan imaging
Lectin blotting and glycan-specific antibodies detect changes in N-glycan structures and occupancy. Imaging of tagged glycoproteins can reveal trafficking and localization in cells.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout screens can identify glycosylation genes required for viral replication, immune checkpoint function, or cell fitness. These screens link GO:0006487 components to phenotypes in a unbiased manner.
Biochemical and structural assays
In vitro glycosylation assays with purified oligosaccharyltransferase and acceptor peptides define substrate specificity and catalytic mechanism. Structural studies of the OST complex provide mechanistic insight into en bloc transfer.
How CRISPR Can Be Used to Study GO:0006487 protein N-linked glycosylation
Knockout
CRISPR knockout of glycosylation genes such as OST subunits or glycan-processing enzymes can abolish N-linked glycosylation of target proteins and reveal loss-of-function phenotypes. Knockout models are used to test whether a glycosylation gene is required for viral particle formation, immune checkpoint function, or protein stability.
Point Mutation
CRISPR point mutation can change a specific asparagine in the Asn-X-Ser/Thr sequon to glutamine, preventing glycan attachment at that site while preserving the rest of the protein. This approach is used to dissect site-specific functions of N-glycans in prion protein, viral proteins, and transporters.
Knock-in
CRISPR knock-in can introduce disease-associated glycosylation-site variants or epitope tags into endogenous loci. Knock-in models are valuable for studying how natural glycan variants affect protein trafficking, neurotoxicity, or viral replication.
Overexpression
CRISPR-mediated overexpression or cDNA overexpression of glycosyltransferases can increase specific glycan structures and test gain-of-function effects. Overexpression models are used to study how altered glycosylation of PD-L1/PD-1 affects immune recognition and cancer progression.
How EDITGENE Supports protein N-linked glycosylation Research
Researchers studying protein N-linked glycosylation-related genes often need to determine whether a candidate gene is causally involved in a phenotype, such as viral replication, immune checkpoint regulation, or protein stability. EDITGENE provides CRISPR-based cell models and screening services to test these hypotheses with rigor and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for protein N-linked glycosylation research.
Frequently Asked Questions About protein N-linked glycosylation
What is protein N-linked glycosylation?
Protein N-linked glycosylation (GO:0006487) is the biological process that attaches a preassembled oligosaccharide to the amide nitrogen of an asparagine residue in the Asn-X-Ser/Thr sequon of a nascent polypeptide.
What genes are involved in protein N-linked glycosylation?
Key genes include oligosaccharyltransferase subunits, ALG genes for precursor assembly, and glycan-processing enzymes such as MAN1B1, MGAT1, B4GALT1, ST6GAL1, and FUT8.
Where does N-linked glycosylation occur in the cell?
N-linked glycosylation begins in the endoplasmic reticulum and continues in the Golgi apparatus during glycan maturation.
What is the difference between N-linked and O-linked glycosylation?
N-linked glycosylation attaches glycans to the amide nitrogen of asparagine, whereas O-linked glycosylation attaches glycans to the hydroxyl oxygen of serine or threonine.
Why is N-linked glycosylation important for protein folding?
N-linked glycans promote proper folding and quality control in the endoplasmic reticulum and influence protein stability and trafficking.
How is N-linked glycosylation linked to cancer?
N-linked glycosylation of PD-L1/PD-1 is an emerging target for cancer diagnosis and treatment, and altered glycosylation can affect immune evasion.
Does N-linked glycosylation affect viral infection?
Yes, N-linked glycosylation of flavivirus E protein contributes to viral particle formation, and glycosylation of orthoflavivirus NS1 modulates progeny virion assembly.
Can CRISPR be used to study N-linked glycosylation?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can test the causal role of glycosylation genes and sites.
What diseases are associated with defective N-linked glycosylation?
N-linked glycosylation is linked to cancer, neurodegeneration, and viral pathogenesis, including prion protein neurotoxicity and hepatitis B virus biology.
How can I model N-linked glycosylation in the lab?
Common models include CRISPR knockout cell lines, point mutants of glycosylation sequons, knock-in reporters, and overexpression of glycosyltransferases.
Conclusion
GO:0006487 (protein N-linked glycosylation) is a fundamental biological process that shapes protein folding, stability, trafficking, and interactions. Its roles in viral pathogenesis, cancer immune regulation, and neurodegeneration make it a high-priority area for functional genomics and therapeutic development. CRISPR-based models and glycoproteomic methods provide powerful tools to dissect the pathway and translate findings into clinical applications.
References
- 1. Ishida K et al.. 2023. N-linked glycosylation of flavivirus E protein contributes to viral particle formation.. PLoS Pathog 19(10):e1011681 PMID: 37819933
- 2. Chan MC et al.. 2023. The Effects of N-Linked Glycosylation on SLC6 Transporters.. J Chem Inf Model 63(9):2748-2758 PMID: 37026711
- 3. Schwarz F et al.. 2011. Mechanisms and principles of N-linked protein glycosylation.. Curr Opin Struct Biol 21(5):576-82 PMID: 21978957
- 4. Schilling KM et al.. 2023. N-glycosylation is a potent regulator of prion protein neurotoxicity.. J Biol Chem 299(9):105101 PMID: 37507020
- 5. Duan Z et al.. 2024. N-linked glycosylation of PD-L1/PD-1: an emerging target for cancer diagnosis and treatment.. J Transl Med 22(1):705 PMID: 39080767
- 6. Zhu HJ et al.. 2020. N-Linked Glycosylation Prevents Deamidation of Glycopeptide and Glycoprotein.. ACS Chem Biol 15(12):3197-3205 PMID: 33270417
- 7. Tepjanta P et al.. 2024. The N-linked glycosylation modifications in the hepatitis B surface protein impact cellular autophagy, HBV replication, and HBV secretion.. PLoS One 19(3):e0299403 PMID: 38489292
- 8. Zhang S et al.. 2026. N-linked glycosylation of NS1 protein modulates progeny virion assembly in orthoflaviviruses.. PLoS Pathog 22(7):e1014408 PMID: 42424390
